15099237

Source:http://linkedlifedata.com/resource/pubmed/id/15099237

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0030705, umls-concept:C0032768, umls-concept:C0034380, umls-concept:C0332306, umls-concept:C0392756, umls-concept:C1251704, umls-concept:C1280519, umls-concept:C1320357, umls-concept:C2346501
pubmed:issue	4
pubmed:dateCreated	2004-4-21
pubmed:abstractText	To assess the effectiveness of the lidocaine patch 5% (Lidoderm), a targeted peripheral analgesic, in reducing pain intensity/interference with quality of life (QOL) among patients with postherpetic neuralgia (PHN).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100894201
pubmed:status	PubMed-not-MEDLINE
pubmed:month	Dec
pubmed:issn	1526-2375
pubmed:author	pubmed-author:DavisMatthew WMW, pubmed-author:DworkinRobert HRH, pubmed-author:GammaitoniArnold RAR, pubmed-author:KatzNathaniel PNP, pubmed-author:Lidoderm Patch Study Group
pubmed:issnType	Print
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	324-32
pubmed:year	2002
pubmed:articleTitle	Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.
pubmed:affiliation	Harvard Medical School, Boston, Massachusetts, USA. NatPaulKatz@aol.com
pubmed:publicationType	Journal Article